Dna Methylation in Esophageal Diseases Including Cancer: Special Reference to hMLH1 Gene Promoter Status

Chitra S. , Ashok L. , Anand L. , Srinivasan V. , Jayanthi V. : Risk factors for esophageal cancer in Coimbatore, Southern India: a hospital-based case-control study. Indian J Gastroenterol, 23: 19–21, 2004.

Mayne S.T. , Risch H.A. , Dubrow R. , Chow W.H. , Gammon M.D. , Vaughan T.L. , Farrow D.C. , Schoenberg J.B. , Stanford J.L. , Ahsan H. , West A.B. , Rotterdam H. , Blot W.J. , Fraumeni J.F. Jr. : Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev, 10: 1055–1062, 2001.

Yang C.X. , Wang Y. , Wang Z.M. : Risk factors for esophageal cancer: a case-control study in south-west China. Asian Pac J Cancer Prev, 6: 48–53, 2005.

Kim R. , Weissfeld J.L. , Reynolds J.C. , Kuller L.H. : Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev, 6: 369–377, 1997.

Vaughan T.L. , Farrow D.C. , Hansten P.D. , Chow W.H. , Gammon M.D. , Risch H.A. , Stanford J.L. , Schoenberg J.B. , Mayne S.T. , Rotterdam H. , Dubrow R. , Ahsan H. , West A.B. , Blot W.J. , Fraumeni J.F. Jr. : Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs and other medications that promote gastroesophageal reflux. Cancer Epidemiol Biomarkers Prev, 7: 749–756, 1998.

Li K. , Yu P. : Food groups and risk of esophageal cancer in Chaoshan region of China: a high-risk area of esophageal cancer. Cancer Invest, 21: 237–240, 2003.

Rosai J. : Gastrointestinal tract. In: Ackerman's surgical pathology, Rosai J. (Ed), pp 589–615, Mosby, New York, 1996.

Kagawa Y. , Yoshido K. , Hirai T. , Toge T. , Yokozaki H. , Yasui W. , Tahara E. : Microsatellite instability in squamous cell carcinoma and dysplasias of the esophagus. Anticancer Res, 20: 213–218, 2000.

Bani-Hani K. , Martin I.G. , Hardie L.J. , Mapstone N. , Briggs J.A. , Forman D. , Wild C.P. : Prospective study of cyclin Dl overexpression in Barrett's esophagus: Association with increased risk of adenocarcinoma. J Natl Cancer Inst, 92: 1316–1321, 2000.

Razin A. , Riggs A.D. : DNA methylation and gene regulation. Science, 210: 604–610, 1980.

Kang Y.H. , Bae S.I. , Kim W.H. : Comprehensive analysis of promoter methylation and altered expression of hMLH1 in gastric cancer cell lines with microsatellite instability. J Cancer Res Clin Oncol, 128: 119–124, 2002.

Jiricny J. : Eukaryotic mismatch repair: an update. Mutat Res, 409: 107–121, 1998.

Jiricny J. : Replication errors: cha(lle)nging the genome. EM-BO J, 17: 6427–6436, 1998.

Deng G. , Che A. , Hong J. , Chae H.S. , Kim Y.S. : Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res, 59: 2029–2033, 1999.

Cunningham J.M. , Christensen E.R. , Tester D.J. , Kim C.Y. , Roche P.Q. , Burgart L.J. , Thibodeau S.N. : Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res, 58: 3455–3460, 1998.

Leung S.Y. , Yuen S.T. , Chung L.P. , Chu K.M. , Chan A.S.Y. , Ho J.C.I. : hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res, 59: 159–164, 1999.

Hayashi M. , Tamura G. , Jin Z. , Kato I. , Sato M. , Shibuya Y. , Yang S. , Motoyama T. : Microsatellite instability in esophageal squamous cell carcinoma is not associated with hMLH1 promoter hypermethylation. Pathol Int, 53: 270–276, 2003.

Geddert H. , Kiel S. , Iskender E. , Florl A.R. , Krieg T. , Vossen S. , Gabbert H.E. , Sarbia M. : Correlation of hMLH1 and HPP1 hypermethylation in gastric, but not esophageal and cardiac adenocarcinoma. Int J Cancer, 110: 208–211, 2004.

Stern L. , Mason J. , Selhub J. , Choi S.W. : Genomic DNA hy-pomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev, 9: 849–853, 2000.

Yi P. , Melnyk S. , Pogribna M. , Pogribna I.P. , Hine R.J. , James S.J. : Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem, 275: 29318–29323, 2000.

Bolander-Gouaille C. : Focus on homocysteine and the vitamins involved in its metabolism, pp 20–31, Springer Verlag, Paris, 2002.

Hasan Q. , Vasavi M. , Ahuja Y.R. : (CTG)_n expansion at the DMPK locus seen only in muscle tissue: a novel case. Indian J Exp Biol, 42: 937–940, 2004.

Ruger B.M. , Erb K.J. , He Y. , Lane J.M. , Davis P.F. , Hasan Q. : In-terleukin-4 transgenic mice develop glomerulosclerosis independent of immunoglobulin deposition. Eur J Immunol, 30: 2698–2703, 2000.

Wang Y. , Irish J. , MacMillan C. , Brown D. , Xuan Y. , Boyington C. , Gullane P. , Kamel- Reid S. : High frequency of microsatellite instability in young patients with head-and-neck squamous-cell carcinoma: lack of involvement of the mismatch repair genes hMLH1 and hMSH2. Int J Cancer, 93: 353–360, 2001.

Alluri R.V. , Vasavi M. , Komandur S. , Chawda K. , Chaudhuri J.R. , Hasan Q. : MTHFR C677T gene mutation as a risk factor for arterial stroke: a hospital based study. Eur J Neurol, 12: 40–44, 2005.

Peracchia A. , Segalin A. , Bardini R. , Ruol A. , Bonavina L. , Baessato M. : Esophageal carcinoma and achalasia. Prevalence, incidence and results of treatment. Hepatogastroen-terology, 38: 514–516, 1991.

Meijssen M.A. , Tilanus H.W. , van Blankenstein M. , Hop W.C. , Ong G.L. : Achalasia complicated by esophageal squamous cell carcinoma. A prospective study in 195 patients. Gut, 33: 155–158, 1992.

Cameron A.J. , Ott B.J. , Payne W.S. : The incidence of adenocarcinoma in columnar lined (Barrett's) esophagus. N Engl J Med, 313: 857–859, 1985.

Ishitsuka T. , Kashiwagi H. , Konishi F. : Microsatellite instability in inflamed and neoplastic epithelium in ulcerative colitis. J Clin Pathol, 54: 526–532, 2001.

Gao J.F. , Arbman G. , Wadhra T.I. , Zhang H. , Sun X.F. : Relationships of tumor inflammatory infiltration and necrosis with microsatellite instability in colorectal cancers. World J Gastroenterol, 11: 2179–2183, 2005.

Brentnall T.A. , Chen R. , Lee J.G. , Kimmey M.B. , Bronner M.P. , Haggitt R.C. , Kowdley K.V. , Hecker L.M. , Byrd D.R. : Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis. Cancer Res, 55: 4264–4267, 1995.

Lynch J.P. , Hoops T.C. : The genetic pathogenesis of colorectal cancer. Hematol Oncol Clin North Am, 16: 775–810, 2002.

Bubb V.J. , Curtis L.J. , Cunningham C. , Dunlop M.G. , Carothers A.D. , Morris R.G. , White S. , Bird C.C. , Wyllie A.H. : Microsatellite instability and the role of hMSH2 in sporadic colorectal cancer. Oncogene, 12: 2641–2649, 1996.

Kang Y.H. , Bae S.I. , Kim W.H. : Comprehensive analysis of promoter methylation and altered expression of hMLH1 in gastric cancer cell lines with microsatellite instability. J Cancer Res Clin Oncol, 128: 119–124, 2002.

Liu B. , Nicolaides N.C. , Markowitz S. , Willson J.K.V. , Parsons R.E. , Jen J. , Papadopoulos N. , Peltomaki P. , de la Chapella A. , Hamilton S.R. , Kinzler K.W. , Vogelstein B. : Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet, 9: 48–55, 1995.

Kane M.F. , Loda M. , Gaida G.M. , Lipman J. , Mishra R. , Goldman H. , Jessup J.M. , Kolodner R. : Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair defective human tumor cell line. Cancer Res, 57: 808–811, 1997.

Nie Y. , Liao J. , Zhao X. , Song Y. , Yang G.Y. , Wang L.D. , Yang C.S. : Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma. Carcinogenesis, 23: 1713–1720, 2002.

Wang Y.C. , Lu Y.P. , Tseng R.C. , Lin R.K. , Chang J.W. , Chen J.T. , Shih C.M. , Chen C.Y. : Inactivation of hMLH1 and hMSH2 by promoter methylation in primary nonsmall cell lung tumors and matched sputum samples. J Clin Invest, 111: 887–895, 2003.

Wong T.S. , Kwong D.L. , Sham J.S.T. , Tsao S.W. , Wei W.I. , Kwong Y.L. , Yuen A.P.W. : Promoter hypermethylation of high-in-normal 1 gene in primary nasopharyngeal carcinoma. Clin Cancer Res, 9: 3042–3046, 2003.

Zou H.Z. , Yu B.M. , Wang Z.W. , Sun J.Y. , Cang H. , Gao F. , Li D.H. , Zhao R. , Feng G.G. , Yi J. : Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin Cancer Res, 8: 188–191, 2002.

Lagergren J. , Bergstrom R. , Lindgren A. , Nyren O. : Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med, 340: 825–831, 1999.

McColl K.E. , Gillen D. : Prediction of malignant potential in reflux disease. Am J Gastroenterol, 100: 1012–1018, 2005.

Tran T. , Spechler S.J. , Richardson P. , El- Serag H.B. : Fundopli-cation and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study. Am J Gastroenterol, 100: 1009–1011, 2005.

Kim Y.I. : Folate and carcinogenesis. Evidence, mechanisms, and implications. J Nutr Biochem, 10: 66–88, 1999.

Zhang J. , Zotz R.B. , Wang R. , Kiel S. , Schulz W.A. , Wen D. , Chen Z. , Zhang L. , Wang S. , Gabbert H.E. , Sarbia M. : Methyl-enetetrahydrofolate reductase C677T polymorphism and predisposition towards esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population. J Cancer Res Clin Oncol, 130: 574–580, 2004.

Miao X. , Xing D. , Tan W. , Qi J. , Lu W. , Lin D. : Susceptibility to gastric cardia adenocarcinoma and genetic polymorphisms in methylenetetrahydrofolate reductase in an at-risk Chinese population. Cancer Epidemiol Biomarkers Prev, 11: 1454–1458, 2002.

Shannon B. , Gnanasampanthan S. , Beilby J. , Iacopetta B. : A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability. Gut, 50: 520–524, 2002.

Baylin S. , Herman J. , Graff J. , Vertino P.M. , Issa J.P. : Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res, 72: 141–196, 1998.

Issa J.P. : Aging, DNA methylation and cancer. Crit Rev Oncol Hematol, 32: 31–43, 1999.